Recent studies have shown that bone morphogenetic proteins (BMPs) are important regulators in the pituitary-gonadal endocrine axis. We here investigated the effects of BMPs on GNRH production controlled by estrogen using murine GT1-7 hypothalamic neuron cells. GT1-7 cells expressed estrogen receptor a (ERa; ESR1 as listed in MGI Database), ERb (ESR2 as listed in MGI Database), BMP receptors, SMADs, and a binding protein follistatin. Treatment with BMP2 and BMP4 had no effect on Gnrh mRNA expression; however, BMP6 and BMP7 significantly increased Gnrh mRNA expression as well as GnRH production by GT1-7 cells. Notably, the reduction of Gnrh expression caused by estradiol (E 2 ) was restored by cotreatment with BMP2 and BMP4, whereas it was not affected by BMP6 or BMP7. E 2 activated extracellular signal-regulated kinase (ERK) 1/2 and stress-activated protein kinase/c-Jun NH 2 -terminal kinase (SAPK/JNK) signaling but did not activate p38-mitogenactivated protein kinase (MAPK) signaling in GT1-7 cells. Inhibition of ERK1/ERK2 reversed the inhibitory effect of estrogen on Gnrh expression, whereas SAPK/JNK inhibition did not affect the E 2 actions. Expression levels of Era and Erb were reduced by BMP2 and BMP4, but were increased by BMP6 and BMP7. Treatment with an ER antagonist inhibited the E 2 effects on Gnrh suppression including reduction of E 2 -induced ERK phosphorylation, suggesting the involvement of genomic ER actions in Gnrh suppression. BMP2 and BMP4 also suppressed estrogen-induced phosphorylation of ERK1/ERK2 and SAPK/JNK signaling, suggesting that BMP2 and BMP4 downregulate estrogen effects by attenuating ER-MAPK signaling. Considering that BMP6 and BMP7 increased the expression of a1E-subunit of R-type calcium channel (Cacna1e), which is critical for GNRH secretion, it is possible that BMP6 and BMP7 directly stimulate GNRH release by GT1-7 cells. Collectively, a newly uncovered interaction of BMPs and ER may be involved in controlling hypothalamic GNRH production and secretion via an autocrine/paracrine mechanism.
Introduction
Reproduction in mammals is controlled by the coordination between episodic release of GNRH and GNRH-dependent secretion of pituitary gonadotropins. GNRH is a highly conserved decapeptide, which is secreted by a scattered group of cells located in the hypothalamus. The pattern of GNRH secretion is regulated by the intrinsic oscillatory activity of GNRH neurons and the integration of presynaptic inputs of various neurotransmitters. GNRH synthesis and release are tightly regulated by gonadal steroids, which maintain control through a negative feedback system (Petersen et al. 2003) . In females, estrogens act directly or indirectly on GNRH neuronal network to modulate the final output of GNRH into the median eminence (Herbison 1998 , Herbison & Pape 2001 . Estrogen receptors (ER) belong to the superfamily of nuclear receptors and are classified as class I ligand-activated transcription factors. There are two identified subtypes of ERa and ERb (ESR1 and ESR2 as listed in MGI Database), which are encoded by separate genes and differ in structure, function, and anatomical distribution.
The characterization of specific estrogen effects and identification of ER-dependent signaling pathways have been difficult in GNRH neurons. In this respect, immortalized GNRH-producing GT1-7 cells have proven to be a valuable tool to study the biology of GNRH neurons (Liposits et al. 1991 . Although earlier studies indicated that GNRH neurons generally lack steroid hormone receptors, recent studies have provided evidence that GT1-7 cells express functional ER, suggesting that estrogen regulates GNRH production and secretion directly in GNRH neuron in the reproductive system composed of hypothalamo-pituitary-ovarian (HPO) axis.
Bone morphogenetic proteins (BMPs), which belong to the transforming growth factor-b (TGF-b or TGFB1 as listed in MGI Database) superfamily, were originally identified as the active components in bone extracts capable of inducing bone formation at ectopic sites. Recent studies have shown that BMPs are crucial molecules in normal folliculogenesis by regulating gonadotropin-induced steroidogenesis and mitosis in ovarian granulosa cells (Otsuka et al. 2000 , Otsuka & Shimasaki 2002a , Shimasaki et al. 2004 . The major regulatory process by BMPs in ovarian steroidogenesis is the control of FSH receptor signaling (Otsuka et al. 2001a,b) , leading to normal follicular development in the ovary with prevention of immature ovulation. Furthermore, the pituitary BMP system acts as a regulator not only for pituitary differentiation but also for the transformation of differentiated pituitary cells (Otsuka & Shimasaki 2002b , Takeda et al. 2003 . It is of note that BMPs activate FSH production by the pituitary gonadotrope (Huang et al. 2001 , Otsuka & Shimasaki 2002b , Nicol et al. 2008 . Functional communication between the ovary and central nervous system ensures that the neural signal for ovulation occurs when ovarian follicles are fully matured. Hence, BMPs play crucial roles in female reproduction not only by regulating ovarian steroidogenesis and mitogenesis but also by activating pituitary gonadotropin secretion in an autocrine/paracrine manner.
However, the effects of BMPs on hypothalamic GNRH production and secretion have yet to be elucidated. In the present study, we here investigated the effects of BMPs on GNRH production controlled by estrogen using murine GT1-7 hypothalamic neuron cells. A novel interaction between BMPs and ER, which is involved in controlling hypothalamic GNRH production and secretion, was here uncovered.
Materials and Methods

Reagents and supplies
DMEM, dimethyl sulfoxide, penicillin-streptomycin solution, 17b-estradiol (E 2 ), BSA-conjugated E 2 (E 2 -BSA), ICI 182 780 (also called fulvestrant), and recombinant human activin A were purchased from Sigma-Aldrich Co. Ltd. Recombinant human BMP-2, -4, -6, and -7 were purchased from R&D Systems Inc. (Minneapolis, MN, USA), recombinant human platelet-derived growth factor (PDGF)-BB was purchased from PeproTech (London, UK), and U0126 and SB203580 were purchased from Promega Corp. SP600125 was purchased from Biomol Lab. Inc (Plymouth Meeting, PA, USA). Mouse ovary total RNA was purchased from Ambion (Austin, TX, USA). For the experiments using E 2 -BSA, the preparation of E 2 -BSA free of estradiol was performed as previously reported (Taguchi et al. 2004 , Takahashi et al. 2008 : 4 ml E 2 -BSA (1 . 25 mM in estrogen dissolved in 50 mM Tris-HCl (pH 8 . 5)) was added to a Amicon Ultra centrifugal filter unit with a MW cut off of 5000 (Millipore, Bedford, MA, USA) and centrifuged at 4000 g until 50 ml retentate remained. The retentate was washed with Tris buffer, and final volume was adjusted to 5 ml (1 mM). GT1-7 cell culture GT1-7 cells were kindly provided by Dr Pamela L Mellon, University of California, San Diego, CA, USA. GT1-7 cells were maintained in DMEM supplemented with 10% FCS, penicillin, and streptomycin (Sigma-Aldrich Corp.) at 37 8C in 5% CO 2 humidified atmosphere. The culture medium was changed twice a week, and cultures were passaged at w80% confluence. Changes in cell morphology and growing conditions were carefully monitored under an inverted microscope.
RNA extraction, RT-PCR, and quantitative real-time PCR analysis GT1-7 cells (2!10 5 viable cells/ml) were precultured in serum-free DMEM, and cells were treated with indicated concentrations of BMPs in combination with E 2 and various chemical inhibitors including U0126, SB203580, SP600125, and ICI 182 780. After 24-h culture, the medium was removed, and total cellular RNAs were extracted using TRIzol (Invitrogen Corp.), subsequently quantified by measuring absorbance at 260 nm and stored at K80 8C until assay. The expression of BMP receptors (Bmprs), Smads, Ers, and Gnrh was detected by RT-PCR analysis. The extracted RNA (1 mg) was subjected to a RT reaction using First-Strand cDNA Synthesis System (Invitrogen Corp.) with random hexamer (2 ng/ml), reverse transcriptase (200 U), and dNTP (0 . 5 mM) at 42 8C for 50 min, 70 8C for 10 min.
Subsequently, hot-start PCR was performed using MgCl 2 (1 . 5 mM), dNTP (0 . 2 mM), and Taq DNA polymerase (2 . 5 U) (Invitrogen Corp). Oligonucleotides used for PCR were custom ordered from Invitrogen Corp. PCR primer pairs were selected from different exons of the corresponding genes to discriminate PCR products that might arise from possible chromosome DNA contaminants. The primer pairs for mouse BMP receptors, Smads, and a housekeeping gene, ribosomal protein-L19 (Rpl19 ), were selected as reported (Kano et al. 2005 . For Ers, Gnrh, and calcium channel a1E-subunit (Cacna1e) genes, the following sequences were used: Era, 1523-1543 and 1737-1757 from GenBank accession number NM_007956; Erb, 701-721 and 1004-1024 from NM_010157; Gnrh, 90-110 and 316-336 from BC116897; and calcium channel a1E, 3181-3201 and 3403-3423 from NM_009782. The aliquots of PCR products were electrophoresed on 1 . 5% agarose gels and visualized after ethidium bromide staining. For the quantification of Gnrh, Era, Erb, Cacna1e, and Rpl19 mRNA levels, real-time PCR was performed using LightCycler FastStart DNA master SYBR Green I system (Roche Diagnostic Co.) under each optimized condition of annealing at 59-63 8C with 4 mM MgCl 2 , following the manufacturer's protocol. Accumulated levels of fluorescence for each product were analyzed by the second derivative method after the melting curve analysis (Roche Diagnostic Co.), and then, following the assay validation by calculating each amplification efficiency (Rpl19, 98 . 5%; Gnrh, 89%; Era, 88%; Erb, 92%; and calcium channel a1E, 105%), the expression levels of target genes were quantified based on standard curve analysis for each product and normalized by Rpl19 level in each target.
Measurement of GNRH production
To assess the effects of BMPs on GNRH protein synthesis, GT1-7 cells (2!10 5 viable cells/ml) were cultured in 96-well plates with DMEM containing 10% FCS for 24 h. The medium was then changed to serum-free DMEM and subsequently treated with the indicated concentrations of BMPs and E 2 . After 24-h culture, the supernatant of the culture media was collected and stored at K80 8C until assay. GNRH concentration (pg/ml) in the conditioned medium was determined by RIA as previously reported (Chappell et al. 2003 ). Briefly, 0 . 1 ml aliquots of each sample were incubated for 48 h with GNRH antibody EL-14 at 4 8C, after which time 10 000 c.p.m. sample of radio-iodinated GNRH (Amersham Pharmacia) was added. Following ethanol precipitation of the bound fractions after 48-h incubation, radioactivity was detected by a gamma scintillation counter (Micromedic, Huntsville, AL, USA), and the standard curve analysis was performed at each assay. The inter-and intra-assay variability are 8 . 7 and 7 . 7% respectively in the current RIA.
Thymidine incorporation assay GT1-7 cells (1!10 5 viable cells/ml) were precultured in 12-well plates with DMEM containing 10% FCS for 24 h. After preculture medium was replaced with fresh serum-free medium and indicated concentrations of E 2 , BMPs and PDGF-BB were added to the culture medium. After 24-h culture, 0 . 5 mCi/ml [methyl-3 H] thymidine (Amersham Pharmacia) was added and incubated for 3 h at 37 8C. The incorporated thymidine was detected as previously reported (Takahashi et al. 2008) . Cells were then washed with PBS, incubated with 10% ice-cold trichloroacetic acid for 60 min at 4 8C, and solubilized in 0 . 5 M NaOH, and radioactivity was determined with a liquid scintillation counter (TRI-CARB 2300TR, Packard Co., Meriden, CT, USA).
Western immunoblot analysis GT1-7 cells (1!10 5 viable cells/ml) were precultured in 12-well plates in serum-free DMEM. After 24-h preculture, BMPs and activin A (100 ng/ml) were added to the culture medium either alone or in combination with E 2 (100 nM). After acute (10-60 min) or chronic (24 h) stimulations with indicated concentrations of BMPs in combination with E 2 and various chemical inhibitors including U0126, SB203580, SP600125, and ICI 182 780, cells were solubilized in 100 ml RIPA lysis buffer (Upstate Biotechnology, Lake Placid, NY, USA) containing 1 mM Na 3 VO 4 , 1 mM NaF, 2% SDS, and 4% b-mercaptoethanol.
Figure 1 Expression of BMP system and estrogen receptor (ER) in GT1-7 cells. (A) Total cellular RNAs were extracted from GT1-7 cells and quantified by measuring the absorbance of the sample at 260 nm. The expression of mRNAs encoding Alk-2, -3, -4, -6, Bmpr2, Actr2a, Actr2b, Fst, Smad1-8, Gnrh, Era, Erb, and a housekeeping gene Rpl19 was examined by RT-PCR analysis in GT1-7 cells compared with a control sample extracted from mouse ovarian tissues. Aliquots of PCR products were electrophoresed on 1 . 5% agarose gel, visualized by ethidium bromide staining, and shown as representative of those obtained from three independent experiments. MM indicates molecular weight marker. (B) GT1-7 cells were precultured for 24 h and stimulated with BMP-2 and -4 (100 ng/ml) for 1 h. Immunofluorescence (IF) studies were performed using anti-phospho-SMAD1, 5, 8 (pSMAD1, 5, 8) antibody on BMP-treated cells. DAPI indicates counterstaining with 4 0 ,6 0 -diaminodino-2-phenylindole. Bars indicate 20 mm in size.
The cell lysates were then subjected to SDS-PAGE/immunoblotting analysis as previously reported ), using anti-phospho-and anti-totalextracellular signal-regulated kinase (ERK) 1/2 mitogenactivated protein kinase (MAPK) antibody (Cell Signaling Technology, Inc., Beverly, MA, USA), anti-phospho-and anti-total-p38 MAPK antibody (Cell Signaling Technology, Inc.), anti-phospho-and anti-total-stress-activated protein kinase/c-Jun NH 2 -terminal kinase (SAPK/JNK) MAPK antibody (Cell Signaling Technology, Inc.), anti-phospho-Smad1, 5, 8 (pSmad1, 5, 8) antibody (Cell Signaling Technology, Inc.), anti-Smad5 antibody (Cell Signaling Technology, Inc.), anti-actin antibody (Sigma-Aldrich Co. Ltd), and anti-ERa (MC-20), and anti-ERb (H-150) antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
Immunofluorescence microscopy
For the immunofluorescence study, GT1-7 cells were precultured in serum-free DMEM using chamber slides (Nalge Nunc Int, Naperville, IL, USA). Cells at w50% confluency were treated with BMP-2 and BMP-4 (100 ng/ml) for 1 h. Cells were then fixed with 4% paraformaldehyde in PBS, permeabilized with 0 . 5% Triton X-100 in PBS at room temperature, and washed thrice with PBS. The cells were then incubated with anti-phospho-SMAD1, 5, 8 antibody (Cell signaling Technology, Inc.) for 1 h and washed thrice with PBS, then with Alexa Fluor 488 anti-rabbit IgG (Invitrogen Corp.) in humidified chamber for 1 h and washed with PBS, followed by application of the counter medium containing 4 0 ,6 0 -diaminodino-2-phenylindole (Invitorogen Corp.), and then stained cells were visualized under a fluorescent microscope.
Transient transfection and luciferase assay GT1-7 cells (1!10 5 viable cells/ml) were precultured in 12-well plates in DMEM with 10% FCS for 24 h. The cells were transiently transfected with 500 ng Gnrh-luc reporter plasmid, which contains 173-bp rat Gnrh promoter region (Nelson et al. 2000) , and 50 ng cytomegalovirus-b-galactosidase plasmid (pCMV-b-gal) using FuGENE6 (Roche Molecular Biochemicals) for 24 h. The cells were then treated with indicated concentrations of BMPs and E 2 for 24 h in serum-free fresh medium. After 24-h culture, the cells were washed with PBS and lysed with Cell Culture Lysis Reagent (Toyobo, Osaka, Japan). Luciferase activity and b-gal activity of the cell lysate were measured by luminescencer-PSN (ATTO, Tokyo, Japan) as previously reported . The data were shown as the ratio of luciferase to b-gal activity. 
Results
We first examined mRNA expression of the BMP type I and type II receptors in GT1-7 cells by RT-PCR. As shown in Fig. 1A , the BMP type I receptors including activin receptorlike kinase (Alk2) (also called Actr1a), Alk3 (Bmpr1a), and Alk4 (Actr1b), BMP type II receptors including Bmpr2, Actr2, and Actr2b, and a binding protein Fst were clearly expressed in GT1-7 cells. Compared with mouse ovary RNA positive control, the expression of Alk6 (Bmpr1b) was not detected in GT1-7 cells. In addition, mRNA expression of Smad signaling molecules including Smad1, 2, 3, 4, 5, and 8, and inhibitory Smad6 and 7 was also detected (Fig. 1A) . The expression of two subtypes of ERs including Era and Erb, and Gnrh mRNA was also confirmed in GT1-7 cells. As shown in Fig. 1B , the immunofluorescence study demonstrated the nuclear localization of phosphorylated SMAD1, 5, 8 molecules in GT1-7 cells stimulated by BMP-2 and -4 (100 ng/ml), indicating that the BMP receptors and SMADs are functionally active in GT1-7 cells.
To investigate the BMP effects on Gnrh transcription, Gnrh-promoter activity was examined in GT1-7 cells transiently transfected with a Gnrh-luc reporter plasmid containing 173-bp rat Gnrh promoter region (Nelson et al. 2000) . In GT1-7 hypothalamic neurons, a neuron-specific enhancer responsible for directing expression of the rat Gnrh gene was identified (Whyte et al. 1995) , in which w300-bp upstream region confers enhancer activity to a 173-bp Gnrh promoter specifically in GT1-7 cells. In the present study, in order to simply examine Gnrh promoter activity induced by BMPs, only the key promoter region containing 173-bp rat Gnrh promoter was utilized for this promoter assay. As a result, BMP6 and BMP7 stimulated transcriptional activity of Gnrh gene, while BMP2 and BMP4 had no significant effects on Gnrh-promoter activity ( Fig. 2A) . To further examine the BMP effects on steady-state Gnrh mRNA levels in GT1-7 cells, cells were treated with BMP ligands for 24 h in serumfree conditions. Treatment with BMP2 and BMP4 (10 and 100 ng/ml) had no effect on Gnrh mRNA expression by GT1-7 cells (Fig. 2B ). In accordance with the results of Gnrh promoter assay, BMP6 and BMP7 (10 and 100 ng/ml) significantly increased Gnrh mRNA expression ( Fig. 2B ).
In addition, treatment with E 2 (1-100 nM) significantly decreased Gnrh-luc activity (Fig. 3A) and Gnrh mRNA expression levels (Fig. 3B) . Notably, E 2 (100 nM)-induced reduction of Gnrh mRNA was reversed by treatment with BMP2 and BMP4. In contrast, E 2 -induced Gnrh suppression was not apparently affected by treatment with BMP6 and BMP7 (100 ng/ml; Fig. 3B ). Effects of BMPs and estradiol on GT1-7 cell proliferation. GT1-7 cells (1!10 5 cells/ml) were treated with indicated concentrations of estradiol, BMP-2, -4, -6, -7, and PDGF-BB for 24 h in serum-free condition, and then thymidine uptake assay was performed. Results are shown as meanGS.E.M. of data from at least three separate experiments, each performed with triplicate samples.
The effects of BMPs on GNRH production were evaluated by measuring GNRH concentration in the conditioned medium by RIA (Fig. 4A ). In accordance with the results of Gnrh transcription, BMP6 and BMP7 increased GNRH concentration (pg/ml) by GT1-7 cells, while E 2 , BMP2, and BMP4 had no effects on the GNRH levels ( Fig. 4A ). To investigate the involvement of BMPs in GNRH release by GT1-7 cells, the expression changes in a key calcium channel, a1E-subunit were examined (Watanabe et al. 2004) . Various stimuli including potassium and acetylcholine have known to induce GNRH secretion through increased influx of intracellular calcium by GT1-7 cells. The a1E-subunit of R-type calcium channel was recently shown to be critical for GNRH secretion in GT1-7 cells (Watanabe et al. 2004 ). BMP6 and BMP7 increased mRNA expression of a1Esubunit of R-type calcium channel, although E 2 , BMP2, and BMP4 had no effects on a1E-subunit mRNA (Fig. 4B ). In addition, the levels of thymidine incorporation in GT1-7 cells were not increased in response to treatment with E 2 , BMP-2, -4, -6, and -7, although GT1-7 cells were responsive to exogenous PDGF-BB ( Fig. 5) . It is thus possible that BMP6 and BMP7 may directly enhance GNRH release through upregulating a critical calcium channel expression in GT1-7 cells.
Western blots also showed SMAD1, 5, 8 signaling activation by BMP-2, -4, -6, and -7 in GT1-7 cells (Fig. 6A) . Treatments with in particular BMP2 and 4, activated Smad1, 5, 8 phosphorylation in GT1-7 cells (Fig. 6B) . The BMP-induced SMAD1, 5, 8 activation was not affected in the presence of E 2 (100 nM). It was of note that treatment with E 2 (100 nM) significantly activated MAPK phosphorylation including ERK1/ERK2 and SAPK/JNK but not p38-MAPK signaling (Fig. 6A) . BMP-2 and BMP-4 significantly suppressed E 2 (100 nM)-induced phosphorylation of ERK1/ERK2 and SAPK/JNK signaling, whereas BMP6 and BMP7 did not affect E 2 -induced activation of ERK1/ERK2 and SAPK/ JNK (Fig. 6B) . Activin A (100 ng/ml) induced p38 phosphorylation in the presence or absence of E 2 , while activin A did not affect E 2 -induced ERK1/ERK2 activation.
Since treatment with E 2 activated MAPK pathways including ERK1/ERK2 and SAPK/JNK signaling, the functional roles of these pathways in Gnrh transcription were examined. Treatment with 3 mM U0126 specifically inhibited basal and E 2 -induced ERK1/ERK2 phosphorylation ( Fig. 7A ). SP600125 (3 and 10 mM) inhibited basal and E 2 -induced SAPK/JNK phosphorylation in GT1-7 cells, Figure 6 Effects of BMPs and estradiol on SMAD/MAPK signaling in GT1-7 cells. (A) Cells (1!10 5 cells/ml) were precultured for 24 h in serum-free condition and stimulated with BMP-2, -4, -6, -7, and activin A (100 ng/ml) in the absence or presence of estradiol (100 nM). After 60-min culture, cells were lysed and subjected to SDS-PAGE/immunoblotting (IB) analysis using anti-phospho- SMAD1, 5, 8 (pSMAD1, 5, 8) and anti-SMAD5, anti-phospho-ERK1/2 (pERK1/2) and anti-total-ERK1/2 (tERK1/2), anti-phospho-SAPK/JNK (pSAPK/JNK) and anti-total-SAPK/JNK (tSAPK/JNK), anti-phospho-p38 (pp38) and anti-total-p38 (tp38), and anti-actin antibodies. The results shown are representative of those obtained from three independent experiments. (B) The relative integrated density of each protein band of Fig. 6A was digitized by NIH image J 1.34s. Results are shown as meanGS.E.M. of data from at least three separate experiments, each performed with triplicate samples. **P!0 . 01 and *P!0 . 05 versus control or basal levels.
H OTANI and others . BMP effects on GnRH production although SB203580 (3 mM) did not affect either ERK1/ ERK2 or SAPK/JNK phosphorylation (Fig. 7A ). As shown in Fig. 7B, U0126 (3 mM) restored the E 2 -induced suppression of Gnrh expression, although either U0126 or SP600125 alone had no significant effects on Gnrh expression in GT1-7 cells. In contrast, SP600125 (10 mM) failed to reverse the inhibitory effect of estrogen on Gnrh expression. Thus, the effects of estrogen on Gnrh suppression occur through ERK1/ERK2 activation in GT1-7 cells.
We next investigated whether the E 2 actions on MAPK activation and Gnrh suppression are mediated via ER. As shown in Fig. 8A , ERK1/ERK2 phosphorylation induced by E 2 (100 nM) was inhibited in the presence of a competitive ER antagonist ICI 182 780 (30-300 nM), although ICI 182 780 alone had no effects on ERK phosphorylation. A membrane-impermeable E 2 -BSA (100 nM) formulation failed to activate ERK1/ERK2 pathway (Fig. 8A) . Notably, treatment with ICI 182 780 reversed the E 2 -induced suppression of Gnrh mRNA, whereas ICI 182 780 (30 nM) or E 2 -BSA (100 nM) alone did not change the Gnrh expression in GT1-7 cells (Fig. 8B) . These suggest that estrogen inhibits Gnrh expression in GT1-7 cells at least in part by activating ERK1/ERK2 pathway via classic ER. Given the finding that BMP2 and BMP4 suppressed estrogeninduced phosphorylation of MAPK signaling, BMP2 and BMP4 may regulate the ER activity leading to GNRH reduction in GT1-7 cells.
To further investigate the involvement of ER in BMPinduced Gnrh regulation, the expression levels of Era and Erb mRNA were examined in GT1-7 cells treated with BMPs and E 2 . BMP2 and BMP4 (10-100 ng/ml) significantly decreased mRNA levels of Era and Erb, while BMP6 and BMP7 increased the expression of Era and Erb (Fig. 9A  and B ). E 2 (100 nM) itself also decreased Era mRNA levels in GT1-7 cells. In addition, the changes of ERa and ERb protein levels were examined by western immunoblotting in GT1-7 cell lysates treated with BMP-2, -4, -6, and -7 for 24 h. As shown in Fig. 9C , the expression levels of ERa (66 kDa) and ERb (56 kDa) proteins were decreased by BMP2 and BMP4, while BMP6 and BMP7 in turn increased ERa and ERb protein expression, although the levels of an internal control actin (42 kDa) were unchanged in GT1-7 cells. Thus, BMP2 and BMP4 are likely to downregulate estrogen effects by attenuating estrogen-induced ERK1/ ERK2 activation and by suppressing the expression of ER in GT1-7 cells.
Discussion
The episodic secretion of pituitary gonadotropin is essential for the maintenance of the mammalian reproductive cycle and normal gonadal function. In the present study, we showed that hyopothalamic GT1-7 neuron cells express functional machinery of the BMP system, and that the BMP system acts to modulate estrogen effects on Gnrh regulation. E 2 suppressed GNRH production by activating the MAPK pathway through ER action. In this feedback loop between E 2 and GNRH, BMP2 and BMP4 suppress estrogen effects by attenuating estrogen ERK signaling with reduction of ERa and ERb expression. In contrast, BMP6 and BMP7 directly Figure 7 Effects of MAPK inhibition on Gnrh regulation by GT1-7 cells. (A) GT1-7 cells (1!10 5 cells/ml) were precultured for 24 h and then treated with MAPK inhibitors including U0126, SB203580, and SP600125 (3-10 mM) in combination with estradiol (E 2 ; 100 nM). After 60-min culture, cells were lysed and subjected to SDS-PAGE/immunoblotting (IB) analysis using anti-phospho-ERK1/2 (pERK1/2), anti-total-ERK1/2 (tERK1/2), anti-phospho-SAPK/JNK (pSAPK/JNK), and anti-total SAPK/JNK (tSAPK/JNK) antibodies. The results shown are representative of those obtained from three independent experiments. (B) GT1-7 cells (2! 10 5 cells/ml) were treated with U0126 (3 mM) and SP600125 (10 mM) in the absence or presence of estradiol (100 nM) in serumfree conditions for 24 h. Total cellular RNA was extracted and Gnrh mRNA levels were examined by real-time RT-PCR. The expression levels of target genes were standardized by Rpl19 level in each sample. Results are shown as meanGS.E.M. of data from at least three separate experiments, each performed with triplicate samples.
stimulated Gnrh transcription and secretion by GT1-7 cells. This novel interaction of BMPs and ER action is likely involved in controlling hypothalamic GNRH release in an autocrine/paracrine mechanism (Fig. 10) .
Estrogen has rapid regulatory effects on membraneassociated and intracellular responses (often referred to as nongenomic actions), in addition to the well-defined genomic actions in the nucleus. In the present study, E 2 readily activated MAPK phosphorylation including ERK1/ERK2 and SAPK/JNK but not p38-MAPK signaling, implying the involvement of nongenomic effects of estrogen in GT1-7 cells. BMP2 and BMP4 suppressed the estrogen-induced phosphorylation of ERK1/ERK2 and SAPK/JNK signaling, whereas BMP6 and BMP7 did not affect the E 2 -induced activation of ERK1/ERK2 and SAPK/JNK. Since the inhibition of ERK1/ERK2 restored the E 2 -induced suppression of Gnrh expression by GT1-7 cells, the effects of estrogen on Gnrh suppression is likely to occur through ERK1/ERK2 pathway in GT1-7 cells.
These estrogen effects may be distinct from the genomic actions of estrogen and are attributable to its interactions with membrane-bound receptors and other cellular components (Pietras & Szego 1999 , Pietras et al. 2005 . Membrane ER has been observed in the hypothalamus and other brain regions, including the cortex, hippocampus, and brain stem. The extent to which GNRH neurons are directly responsive to steroid hormones has been controversial. However, it is now being accepted that hypothalamic cells express both membrane-associated and nuclear receptors, and that they are capable of directly responding to changes in systemic estrogen (Malyala et al. 2005) .
In our data, ERK1/ERK2 phosphorylation induced by E 2 was inhibited in the presence of ICI 182 780, an ER antagonist that inhibits both ERa and ERb activities. In addition, the effects of membrane-impermeable E 2 -BSA were much less effective than E 2 for activating ERK1/ERK2 signaling in GT1-7 cells. ICI 182 780 reversed the E 2 -induced suppression of Gnrh mRNA and E 2 -BSA failed to suppress Gnrh expression in GT1-7 cells. These findings suggest that estrogen inhibits Gnrh expression, at least in part, by activating ERK1/ERK2 pathway via classic ER signaling. Given the finding that BMP2 and BMP4 suppressed estrogen-induced phosphorylation of MAPK signaling, including ERK1/ERK2, BMP2, and BMP4, may directly regulate the ER activity leading to GNRH reduction in GT1-7 cells.
In agreement with our present results, Roy et al. (1999) demonstrated that E 2 represses Gnrh gene expression in GT1-7 cells. This estrogen effect was blocked by ICI 182 780 and also mimicked by 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane, a putative ERa agonist and ERb antagonist (Gaido et al. 1999 , Roy et al. 1999 ), suggesting that ERa may be responsible for the repressive effects of E 2 on Gnrh expression. However, a phytoestrogen, coumestrol, also suppressed Gnrh expression, which was in turn blocked by an ERb antagonist, R,R-tetrahydrochrysene (Bowe et al. 2003) . These results also imply that estrogen negatively regulates Gnrh promoter activity via not only ERa but also ERb in hypothalamic cells. In the present study, the expression levels of both Era and Erb were decreased in GT1-7 cells treated with BMP2 and BMP4, which could be linked to the suppression of estrogen-induced MAPK activation. To the contrary, the expression levels of Era and Erb were increased by BMP6 and BMP7. This effect may be associated with the upregulation of estrogen-GNRH feedback function following the increase in GNRH production caused by BMP6 and BMP7. Figure 8 Effects of estrogen receptor (ER) inhibition on Gnrh regulation by GT1-7 cells. (A) GT1-7 cells (1!10 5 cells/ml) were precultured for 24 h and then treated with ICI 182 780 (30-300 nM), estradiol (E 2 ; 100 nM), and estradiol-BSA (100 nM). After 60-min culture, cells were lysed and subjected to SDS-PAGE/ immunoblotting (IB) analysis using anti-phospho-ERK1/2 (pERK1/2) and anti-total-ERK1/2 (tERK1/2) antibodies. The results shown are representative of those obtained from three independent experiments. (B) GT1-7 cells (2!10 5 cells/ml) were treated with ICI 182 780 (30-100 nM), estradiol (E 2 ; 100 nM), and estradiol-BSA (100 nM) in serum-free conditions for 24 h. Total cellular RNA was extracted and Gnrh mRNA levels were examined by real-time RT-PCR. The expression levels of target genes were standardized by Rpl19 level in each sample. Results are shown as meanGS.E.M. of data from at least three separate experiments, each performed with triplicate samples. *P!0 . 05 versus control groups. H OTANI and others . BMP effects on GnRH production The mechanism whereby estrogen regulates GNRH secretion may be partly due to an indirect effect on the neighboring neurons, wherein estrogen acts in part to stimulate the GNRH and LH surge by turning off inhibitory neurons and turning on excitatory neurons. The principal determinants of GNRH neuronal activity include gonadal steroids, various neuropeptides, and neurotransmitters. In this regard, work from several laboratories has shown that hypothalamic astrocytes release the factors that can stimulate GNRH release (Gallo & Russell 1995 , Melcangi et al. 1995a , Avola et al. 2000 , Buchanan et al. 2000 , Ojeda et al. 2000 , Dhandapani et al. 2003 . Conditioned media collected from purified hypothalamic astrocytes markedly stimulated GNRH release from GT1-7 neurons, an immortalized GNRH neuronal cell line (Buchanan et al. 2000) . A similar GNRH stimulatory effect has been reported with conditioned media from cerebral cortical astrocytes (Melcangi et al. 1995b ). In our current study, E 2 suppressed Gnrh transcription, whereas GNRH protein concentration was not significantly changed in the culture medium. The suppression of Gnrh mRNA was observed in GT1-7 cells in our data and by others (Roy et al. 1999) . Regarding GNRH secretion, Navarro et al. (2003) reported that GNRH release was not affected by picomolar of estrogen in static culture of GT1-7 cells and hypothalamic cells, which was rather up-regulated in the presence of cyclic treatment with progesterone. Given that E 2 did not affect the expression of a key calcium channel for GNRH secretion in GT1-7 cells, E 2 may not directly regulate the GNRH release at least for a certain culture period regardless of the reduction of Gnrh transcription. The discrepancy between transcriptional regulation and secretory process of GNRH needs to be elucidated in a future study.
It has been reported that TGF-b1 as a neuroregulatory factor secreted by astrocytes can modulate GNRH secretion (Melcangi et al. 1995b , Galbiati et al. 1996 , Buchanan et al. 2000 , Zwain et al. 2002 . Additionally, Ojeda et al. have provided evidence in support of a neuroregulatory role for astrocyte-derived TGF-a (Ma et al. 1992 , Ojeda et al. 2000 . Furthermore, neuroactive steroid metabolites such as 3a-hydroxy-5a-pregnan-20-one (3a,5a-THP) are also known to be produced by astrocytes, which are capable of stimulating the release of GNRH both in vitro and in vivo (el-Etr et al. 1995 , Sim et al. 2001 . Given the findings that several BMPs share a neurotropic capacity for dopaminergic neurons with other members of the TGF-b superfamily through glial cells ( Jordan et al. 1997 , Reiriz et al. 1999 , Samanta et al. 2007 , it is presumable that hypothalamic Figure 9 Effects of BMPs and estradiol on estrogen receptor (Er) expression in GT1-7 cells. (A and B) GT1-7 cells were treated with BMP-2, -4, -6, and -7 (10 and 100 ng/ml) and estradiol (100 nM) in serum-free conditions for 24 h. Total cellular RNA was extracted and Era and Erb mRNA levels were examined by real-time RT-PCR. The expression levels of target genes were standardized by Rpl19 level in each sample. Results are shown as meanGS.E.M. of data from at least three separate experiments, each performed with triplicate samples. *P!0 . 05 versus control groups. (C) Cells (1!10 5 cells/ml) were treated with BMP-2, -4, -6, and -7 (100 ng/ml) in serum-free condition.
After 24-h culture, cells were lysed and subjected to SDS-PAGE/immunoblotting (IB) analysis using anti-ERa, anti-ERb, and anti-actin antibodies. The results shown are representative of those obtained from three independent experiments.
Figure 10
A possible mechanism by which BMPs and estrogen regulate GNRH production by GT1-7 cells. Estradiol suppresses GNRH production by inhibiting ERK1/ERK2 pathway via ER. In this feedback system between estradiol and GNRH production, BMP2 and BMP4 downregulate estrogen effects by attenuating estrogen-ERK signaling and ERa and ERb expression. In contrast, BMP6 and BMP7 directly stimulate Gnrh transcription, GNRH production, and GNRH release via increased expression of a1E-subunit of R-type calcium channel, which is critical for GNRH secretion. A new interaction of BMPs and ER action may be involved in controlling hypothalamic GNRH production and secretion in an autocrine/ paracrine mechanism.
